Literature DB >> 1728907

Serum albumin level on admission as a predictor of death, length of stay, and readmission.

F R Herrmann1, C Safran, S E Levkoff, K L Minaker.   

Abstract

We studied the serum albumin level within 48 hours of hospitalization for acute illness to predict in-hospital death, length of stay, and readmission in 15,511 patients older than 40 years. Patients with low serum albumin levels (less than 34 g/L), who made up 21% of the population, were more likely to die, had longer hospital stays, and were readmitted sooner and more frequently than patients with normal albumin levels. The in-hospital mortality was 14% among patients with low albumin levels, as compared with 4% among patients with normal levels. Although the serum albumin level was a nonspecific marker, it was a stronger predictor of death, length of stay, and readmission than age. We conclude that the serum albumin level on admission is an important variable that should be incorporated in severity-of-illness measures based on physiologic indexes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1728907

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  70 in total

1.  One-year serum albumin is an independent predictor of outcomes in kidney transplant recipients.

Authors:  Rebecca Dahlberg; Brenda Muth; Milagros Samaniego; R Michael Hofmann; John Pirsch; Arjang Djamali
Journal:  J Ren Nutr       Date:  2010-05-26       Impact factor: 3.655

2.  Nutritional parameters associated with prolonged hospital stay among ambulatory adult patients.

Authors:  Riccardo Caccialanza; Catherine Klersy; Emanuele Cereda; Barbara Cameletti; Alberto Bonoldi; Chiara Bonardi; Maurizia Marinelli; Paolo Dionigi
Journal:  CMAJ       Date:  2010-10-12       Impact factor: 8.262

3.  An evaluation of serum albumin, root caries, and other covariates in Gullah African Americans with type-2 diabetes.

Authors:  Nicole M Marlow; Elizabeth H Slate; Dipankar Bandyopadhyay; Jyotika K Fernandes; Carlos F Salinas
Journal:  Community Dent Oral Epidemiol       Date:  2010-11-10       Impact factor: 3.383

Review 4.  Best practices for elderly hip fracture patients. A systematic overview of the evidence.

Authors:  Lauren A Beaupre; C Allyson Jones; L Duncan Saunders; D William C Johnston; Jeanette Buckingham; Sumit R Majumdar
Journal:  J Gen Intern Med       Date:  2005-11       Impact factor: 5.128

Review 5.  Chronic kidney disease and its complications.

Authors:  Robert Thomas; Abbas Kanso; John R Sedor
Journal:  Prim Care       Date:  2008-06       Impact factor: 2.907

6.  Using computer-based medical records to predict mortality risk for inner-city patients with reactive airways disease.

Authors:  W M Tierney; M D Murray; D L Gaskins; X H Zhou
Journal:  J Am Med Inform Assoc       Date:  1997 Jul-Aug       Impact factor: 4.497

Review 7.  Clinical Data Reuse or Secondary Use: Current Status and Potential Future Progress.

Authors:  S M Meystre; C Lovis; T Bürkle; G Tognola; A Budrionis; C U Lehmann
Journal:  Yearb Med Inform       Date:  2017-09-11

8.  Comparative Plasma Pharmacokinetics of Ceftriaxone and Ertapenem in Normoalbuminemia, Hypoalbuminemia, and Albumin Replacement in a Sheep Model.

Authors:  Jayesh A Dhanani; Benjamin Ahern; Liad Lupinsky; Karen Jackson; Steven C Wallis; Mohd H Abdul-Aziz; Jeffrey Lipman; Jason A Roberts
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

9.  Endovascular aneurysm repair is associated with less malnutrition than open abdominal aortic aneurysm repair.

Authors:  Cassius Iyad Ochoa Chaar; Tamara N Fitzgerald; Michael Dewan; Matthew Huddle; Felix J Schlosser; Melissa Perkal; Bart E Muhs; Alan Dardik
Journal:  Am J Surg       Date:  2009-11       Impact factor: 2.565

10.  Low serum albumin level as an independent risk factor for the onset of pressure ulcers in intensive care unit patients.

Authors:  Raffaele Serra; Santo Caroleo; Gianluca Buffone; Marina Lugarà; Vincenzo Molinari; Francesco Tropea; Bruno Amantea; Stefano de Franciscis
Journal:  Int Wound J       Date:  2012-11-22       Impact factor: 3.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.